Prognostic factors and efficacy of GDP-R therapy in refractory/relapsed diffuse large B-cell lymphomas not eligible for high-dose therapy
Authors:
- Francesco GhioFGFrancesco Ghio
- Giulia CervettiGCGiulia Cervetti
- Nadia CecconiNCNadia Cecconi
- Matteo PelosiniMPMatteo Pelosini
- Sara GalimbertiSGSara Galimberti
- Riccardo MorgantiRMRiccardo Morganti
- Paola FerrariPFPaola Ferrari
- Andrea NicoliniAndrea Nicolini
- Mario PetriniMPMario Petrini
Open Access
- 1 January 2015
- journal article
- Published by OAE Publishing Inc. in Journal of Cancer Metastasis and Treatment
- Vol. 2, 59-63